This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Sysmex Corporation. Active years: 2011-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2015
Title: Kayo Shoji: Innovator in Cancer Diagnosis
Introduction
Kayo Shoji is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of medical diagnostics, particularly in the area of cancer detection. With a total of 3 patents to her name, her work focuses on innovative methods for diagnosing lymph node metastasis in stomach cancer.
Latest Patents
Kayo Shoji's latest patents include groundbreaking methods and apparatuses for judging lymph node metastasis of stomach cancer. One of her notable inventions provides a novel marker capable of accurately diagnosing this condition. The invention involves an mRNA, or a fragment thereof, coding for at least one protein selected from TFF1, AGR2, PRSS8, MUC1, MUC4, and MUC17, which can serve as a lymph node metastasis marker.
Career Highlights
Kayo Shoji is currently associated with Sysmex Corporation, where she continues to advance her research and innovations. Her work has garnered attention for its potential to improve cancer diagnosis and patient outcomes.
Collaborations
Kayo has collaborated with esteemed colleagues, including Hideki Takata and Kazuki Nakabayashi, to further enhance her research efforts.
Conclusion
Kayo Shoji's contributions to cancer diagnostics exemplify the impact of innovative thinking in medicine. Her patents reflect a commitment to improving diagnostic accuracy and patient care in the fight against stomach cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile